24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
New Phase
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:37
Intel and Weizmann researchers unveil breakthrough to make AI models run faster
22:00
Decart launches real-time AI tool for live video transformation
21:27
Full list of Israeli high-tech layoffs in 2025
21:24
$205M-backed TytoCare cuts 20% of staff, CEO Gilad to transition to chairman role
More stories
Buzz
Most popular
Daily
Weekly
1
Israel orders more Arrow 3 missiles, rushes Arrow 4 to meet hypersonic threats
2
Mapping Israel’s $20B GenAI boom: 342 startups and counting
3
Intel and Weizmann researchers unveil breakthrough to make AI models run faster
4
Oracle CEO: "Some of the best people in the world are here in Israel, and there's no question about that"
5
AT&T buys $650M stake in DriveNets, delivering major payout to founders, employees and early backers
More news
New Phase
2 stories about New Phase
Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.
09.06.24
|
Ariela Karmel
New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments
“We change cancer from a fatal disease to a chronic ailment”
18.09.22
|
CTech
Ofer Shalev, Founder & CEO at New Phase, spoke to CTech during Mind the Tech NY about New Phase and the technology behind the company